openPR Logo
Press release

The Pharmacogenetic Tests Market to Be Driven By Healthcare Cloud Computing

09-12-2022 03:57 PM CET | Health & Medicine

Press release from: Persistence Market Research

The Pharmacogenetic Tests Market to Be Driven By Healthcare

The global Pharmacogenetic Tests Market is expected to grow at a stupendous rate In Upcoming Years. Today calls for prediction tools that are powered by AI to optimize the usage of the resources available. This could also help in crisis management. As such, key market participants are likely to invest in predictive analytics for condoning unforeseen circumstances. These would be preventive steps taken by the enterprises on the whole.

Click Here to Get Free Sample Copy of This Report@ https://www.persistencemarketresearch.com/samples/27505

Pharmacogenetic test, also known as drug-gene test is used to study and determine the interactions of drug and the genetic make-up of the individual. It has been observed that different people react differently with drugs according to the expression of the genes induced by the drug.

The effect of the drug largely depends on the age, lifestyle, environmental conditions and other medications taken by the individual. Such factors are considered in the pharmacogenetic tests to prescribe the right medication and treatment option to the patient.

Pharmacogenetic tests aid the medical professional to choose the best medicine for the person undertaking the test. Pharmacogenetic tests search for the gene variants that may be responsible for influencing the effect of the drug and thereby helps to determine the degree of effect a drug has on the individual.

Pharmacogenetic tests are easy and reliable and require blood or oral swab as the sample material. This evidence-based medication management is gaining recognition for specificity and sensitivity detection. Direct-to-customer services are emerging in the pharmacogenetic test market lately, which facilitates easy result access in a smart device.

The increasing evidence of influence of genes on medications drives the pharmacogenetic test market. Moreover, the rising demand for personalized medicines and precision diagnosis is expected to favor the expansion of the pharmacogenetic test market over the forecast period.

Increasing number reimbursement policies for pharmacogenetic tests by insurance companies is expected to influence the growth of pharmacogenetic tests in the market. Increasing healthcare expenditure and higher adoption of advance products in developed and high-income countries is expected to fuel the growth of pharmacogenetic tests market over the forecast period.

On the contrary, limited evidence for clinical utility and uncertainty regarding the benefits of the pharmacogenetic tests hamper the growth of pharmacogenetic tests in the market. Additionally, higher cost associated with the pharmacogenetic tests are expected to restrict the mass adoption of the product.

Medical and genomic expert is required to the interpretation of the results provided by pharmacogenetic tests which currently have limited access, creating a restraint for expansion of pharmacogenetic test market.

Request For Customization@ https://www.persistencemarketresearch.com/request-customization/27505

Market Segmentation:
Based on Product Type
Single gene tests
Array-based tests
Whole genome sequencing & Next-generation sequencing
Whole exome sequencing

Based on sample
Blood
Saliva

Based on therapeutic area
Oncology
Neurology
Cardiology
Genomics
Immunology and Hypersensitivity
Others

Based on distribution channel
Hospital Pharmacies
Retail Pharmacies
Mail-Order Pharmacies
Direct to Customer Services

Region
North America
Latin America
Europe
Asia Pacific
Middle East & Africa

Click Here to Get this Report@ https://www.persistencemarketresearch.com/checkout/27505

On the basis of geography, the global pharmacogenetic test market is split into seven key regions viz. North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa. Region wise, North America is anticipated to be the leader in the global pharmacogenetic test market owing to the higher healthcare expenditure coupled with increasing number of manufacturers in the region.

Europe is estimated to represent high incremental opportunities between 2018 and 2028 in the pharmacogenetic test market owing to increasing adoption of the products by end users because of higher spending on healthcare. However, MEA and Latin America are expected to witness stagnant growth in the pharmacogenetic test market owing to the absence of manufacturers in the region and lower healthcare expenditure.

Some of the key players operating in the pharmacogenetic test market are Sonic Healthcare, Kailos Genetics, Inc., GENELEX, GENEWIZ, Inc., Rxight, PGXT, Abomics Ltd., OneOme, LLC, Mako Medical Laboratories, Assurex Health, Inc., and Clinical Reference Laboratory, Inc. amongst others.

Contact Us:
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Pharmacogenetic Tests Market to Be Driven By Healthcare Cloud Computing here

News-ID: 2731652 • Views:

More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Persistence Market Research
Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by Sustainability and Supply Chain Efficiency
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Growth - Persistence Market Research
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Healthcare Demand
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained

All 5 Releases


More Releases for Pharmacogenetic

Major Growth Driver Identified in 2025 Pharmacogenetic Testing Market: Impact Of …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Pharmacogenetic Testing Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size of pharmacogenetic testing has seen brisk growth in recent times and is anticipated to surge from $12.37 billion in 2024 to $14.35 billion in 2025, representing a compound annual growth rate (CAGR)
Evolving Market Trends In The Pharmacogenetic Testing Industry: Advancements In …
The Pharmacogenetic Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Pharmacogenetic Testing Market Size During the Forecast Period? The pharmacogenetic testing market size has grown from $12.37 billion in 2024 to $14.35 billion in 2025, with a CAGR of 16.1%. This
Prominent Pharmacogenetic Testing Market Trend for 2025: Advancements In Prescri …
What Are the Projected Growth and Market Size Trends for the Pharmacogenetic Testing Market? In recent years, the pharmacogenetic testing market scale has been expanding swiftly. The forecast predicts an increase from $12.37 billion in 2024 to $14.35 billion in 2025, manifesting a compound annual growth rate (CAGR) of 16.1%. Factors contributing to the growth during the historic period include heightened drug efficiency, the rising popularity of personalized medicine, the escalating
Global Pharmacogenetic Testing Market Growth Prospects, Future Industry Landscap …
"The Business Research Company recently released a comprehensive report on the Global Pharmacogenetic Testing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample
07-11-2023 | Health & Medicine
DBMR
Pharmacogenetic Testing Market is Expected to witness 8.70% CAGR by Forecast 202 …
The credible Pharmacogenetic Testing Market report offer actionable market insights with which businesses can make out sustainable and lucrative strategies. Not to mention, the report analyses the general market conditions such as product price, profit, capacity, production, supply, demand, and market growth rate which supports businesses on deciding upon several strategies. SWOT analysis has been performed while formulating this market document along with many other standard steps of researching, analyzing
Pharmacogenetic Testing Market, Competitive Strategies, Advertising Trends, & Ma …
Pharmacogenetic Testing Market will project a CAGR of 8.70% during the forecast up to 2030.  The increasing popularity of precision medicine mainly enhances the pharmacogenomics market. It has also been seen that increasing research and development expenditure on pharmacogenomics technologies, is in turn, contributing to the fast development of novel products. The high prevalence rate of adverse drug reactions also leads to the increasing adoption of pharmacogenomics in the global market.